US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mineralys Therapeutics, Inc.

13.60

-0.7200-5.03%

Post-market: 13.870.2700+1.99%18:36 EDT

Volume:555.58K

Turnover:7.65M

Market Cap:886.38M

PE:-3.65

High:14.45

Open:14.45

Low:13.54

Close:14.32

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)

BUZZ-Mineralys launches $250 mln equity offering to fund blood pressure drug; shares dip

Mineralys Therapeutics Launches $250 Million Public Offering of Shares

MT Newswires Live

Mineralys Therapeutics Inc - Commenced an Underwritten Public Offering of $250.0 Mln of Shares of Its Common Stock

THOMSON REUTERS

Top Midday Gainers

MT Newswires Live

BUZZ-Mineralys hits near two-year high as blood pressure drug meets trial goals

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes

Promising Potential of Lorundrostat Drives Buy Rating for Mineralys Therapeutics, Inc.

Mineralys' drug for persistent hypertension succeeds in two trials

Mineralys Therapeutics Up Over 55%, on Pace for Record Percent Increase -- Data Talk

Goldman Sachs Remains a Buy on Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics Shares Hit 52-Week High on Hypertension Study Results

Mineralys Therapeutics Shares up 31% After Co's Blood Pressure Drug Meets Goal in Trials

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Primo Brands, Cracker Barrel, Redfin

Mineralys Therapeutics Says Lorundrostat Met Trial Endpoints for Treating Hypertension; Shares Up Pre-Bell

MT Newswires Live

Mineralys Therapeutics Shares Resume Trading, Jump 40% Premarket After Co's Blood Pressure Drug Meets Goal in Trials

THOMSON REUTERS

CORRECTED-UPDATE 2-Mineralys' blood pressure drug meets goal in trials, shares soar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MLYS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":13.6,"timestamp":1753732800000,"preClose":14.32,"halted":0,"volume":555580,"hourTrading":{"tag":"盘后","latestPrice":13.87,"preClose":13.6,"latestTime":"18:36 EDT","volume":11146,"amount":151585.867504,"timestamp":1753742211953},"delay":0,"floatShares":43519403,"shares":65175287,"eps":-3.725148,"marketStatus":"Post-Mkt","change":-0.72,"latestTime":"07-28 19:16:02 EDT","open":14.45,"high":14.45,"low":13.54,"amount":7648123.16928,"amplitude":0.063547,"askPrice":14.5,"askSize":1000,"bidPrice":12.44,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.725148,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1753747200000},"marketStatusCode":4,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":14.32,"preHourTrading":{"tag":"盘前","latestPrice":14.46,"preClose":14.32,"latestTime":"09:29 EDT","volume":2955,"amount":42108.256515,"timestamp":1753709399999},"postHourTrading":{"tag":"盘后","latestPrice":13.87,"preClose":13.6,"latestTime":"18:36 EDT","volume":11146,"amount":151585.867504,"timestamp":1753742211953},"volumeRatio":0.77183,"impliedVol":0.555,"impliedVolPercentile":0.4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":43519403,"roa":"-35.87%","roe":"-56.31%","lyrEps":-3.663179,"volumeRatio":0.77183,"shares":65175287,"dividePrice":0,"high":14.45,"amplitude":0.063547,"preClose":14.32,"low":13.54,"week52Low":8.241,"pbRate":"2.60","week52High":18.38,"institutionHeld":0,"latestPrice":13.6,"committee":-0.818182,"eps":-3.725148,"divideRate":0,"volume":555580,"delay":0,"ttmEps":-3.725148,"open":14.45,"prevYearClose":12.31,"prevWeekClose":14.32,"prevMonthClose":13.53,"prevQuarterClose":13.53,"fiveDayClose":13.62,"twentyDayClose":13.71,"sixtyDayClose":14.21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518720128","title":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720128","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720128?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:57","pubTimestamp":1741715875,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, DisneyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL4N3PU10Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UAL","LU2063271972.USD","LU0957791311.USD","TSYW.SI","CENX","WYNN","HTZ","SYRS","COEP","HUT","LU0320765489.SGD","LU1983299246.USD","TER","EWCZ","SEZL","ILMN","CAR","BLZE","LU0053671581.USD","LU2237957811.SGD","BK4534","STLD","BVS","BK4211","TSVT","AMAL","EXPE","MLYS","LFMD","ARVN","AAL","RELY","WCT","LZMH","LEGN","ALKT","NFE","ELV","LYFT","MASS","LU0106261372.USD","RAY","LU0058720904.USD","LU2362540622.SGD","NVAX","BCRX"],"gpt_icon":1},{"id":"2518742612","title":"Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518742612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518742612?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:57","pubTimestamp":1741701436,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tim Anderson from Bank of America Securities maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Resear...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-its-buy-rating-for-mineralys-therapeutics-inc-mlys?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-sticks-to-its-buy-rating-for-mineralys-therapeutics-inc-mlys?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0},{"id":"2518209740","title":"BUZZ-Mineralys launches $250 mln equity offering to fund blood pressure drug; shares dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209740","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518209740?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:47","pubTimestamp":1741700857,"startTime":"0","endTime":"0","summary":"** Shares of Mineralys Therapeutics MLYS.O down 0.5% at $14.89 early Tues as co looks to raise equity after its stock soared in previous session. ** MLYS shares on Mon hit two-year high, before ending session up 42% at $14.96, after its blood pressure drug, lorundrostat, met main goals in mid- and late-stage trials. commenced $250 mln stock offering to fund development of lorundrostat, as well as working capital, general purposes. ** BofA, Evercore, Goldman Sachs, Stifel and Wells Fargo are jt bookrunners. ** The Radnor, Pennsylvania-based firm has ~49.8 mln shares outstanding for ~$745 mln market cap. ** All 7 analysts covering MLYS are bullish with $33 median PT, LSEG data shows","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL6N3PU0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1267930227.SGD","LU0320765646.SGD","LU1894683348.USD","LU0256863902.USD","BK4504","LU0070302665.USD","LU1162221912.USD","LU1496350171.SGD","LU0170899867.USD","BK4588","LU0640476718.USD","LU0098860793.USD","IE00BFXG1179.USD","BK4581","LU1280957306.USD","LU0868494617.USD","IE00B19Z3B42.SGD","BK4534","LU0053666078.USD","LU0477156797.USD","BK4553","LU0314106906.USD","IE0002270589.USD","IE00B1BXHZ80.USD","IE00BKVL7J92.USD","LU1883839398.USD","LU1506573853.SGD","LU0306806265.USD","LU1791807156.HKD","LU0130102774.USD","BK4207","LU1366192091.USD","MLYS","LU1496350502.SGD","LU0208291251.USD","LU0648000940.SGD","BK4559","LU0052756011.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0417517546.SGD","IE00B19Z3581.USD","LU1074936037.SGD","LU0321505868.SGD","BK4585","LU0648001328.SGD","LU0106831901.USD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2518892207","title":"Mineralys Therapeutics Launches $250 Million Public Offering of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2518892207","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518892207?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:53","pubTimestamp":1741643606,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday it started a $250 million underwritten public offering of shares.Underwriters in the offering will have a 30-day option to buy up to an additional $37.5 milli","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","MLYS"],"gpt_icon":0},{"id":"2518077272","title":"Mineralys Therapeutics Inc - Commenced an Underwritten Public Offering of $250.0 Mln of Shares of Its Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2518077272","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518077272?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:01","pubTimestamp":1741636865,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0LJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2518520936","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2518520936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518520936?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:28","pubTimestamp":1741631308,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday that lorundrostat met primary endpoints in phase 3 Launch-HTN and phase 2 Advance-HTN trials in patients with uncontrolled hypertension or resistant hypertens","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0203347892.USD","JNJ","IE00BGHQF631.EUR","BK4559","LU1057294990.SGD","BK4533","LU1778281490.HKD","RKT.AU","RDFN","PTGX","LU0795875086.SGD","LU2592432038.USD","BK4585","BK4588","LU1074936037.SGD","LU1061106388.HKD","BK4139","LU1732799900.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU0345769128.USD","BK4007","LU1196500208.SGD","IE000M9KFDE8.USD","RKT","BK7084","LU1894683264.USD","LU2430703251.USD","BK4581","IE00B3PB1722.GBP","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU1244550494.USD","LU0289739699.SGD","BK4532","LU0640476718.USD","BK4079","BK4568","MLYS","LU1023059063.AUD","BK4504","LU1059921491.USD","LU1674673428.USD","LU0345770308.USD","LU2129689431.USD","LU1267930813.SGD","BK4592","LU1674673691.USD"],"gpt_icon":1},{"id":"2518069442","title":"BUZZ-Mineralys hits near two-year high as blood pressure drug meets trial goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2518069442","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518069442?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:17","pubTimestamp":1741630669,"startTime":"0","endTime":"0","summary":"BUZZ-Mineralys hits near two-year high as blood pressure drug meets trial goalsUpdates** Drug developer Mineralys Therapeutics' MLYS.O shares rise as much as 73% to a near two-year high of $18.19** St","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT1GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2518089205","title":"Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518089205","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518089205?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:50","pubTimestamp":1741629008,"startTime":"0","endTime":"0","summary":"On Monday, Mineralys Therapeutics, Inc. released topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials of lorundrostat for uncontrolled hypertension  or resistant hypertension .Both trials achieved statistical significance, were clinically meaningful in their prespecified primary efficacy endpoints, and demonstrated a favorable safety and tolerability profile.The Launch-HTN trial met the primary endpoint with lorundrostat 50 mg dose achieved a 16.9 mmHg reduction in systolic blood pressure and a 9.1 mmHg placebo-adjusted reduction assessed by automated office blood pressure at week 6.Also Read: Supermicro’s AI Boom, Liquid Cooling Edge Spark Analyst Confidence In Growth Potential. In January, the U.S. Food and Drug Administration  cleared Mineralys Therapeutics’ Investigational New Drug  Application for a Phase 2 trial of lorundrostat for moderate-to-severe obstructive sleep apnea  and hypertension. The company anticipates initiating the trial in the f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mineralys-therapeutics-unveils-positive-data-175008973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2518272737","title":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272737?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:12","pubTimestamp":1741623158,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXE","TRVI","W","ABNB","NOVA","MLYS","TKO","REGN","IH","HUT","CME","NEM","LU0354030511.USD","SXTC","BK4599","MNDR","LU0889565833.HKD","NOW","FENC","RDFN","MCHP","ADM","SMC","CKPT","BKKT","ALKT","DASH","BK4607","WLFC","STSS","PRMB","RKT","TSYW.SI","BECN","ENPH","CBRL","WSM","PTGX","DXCM","LU0048584097.USD","LU0289739699.SGD","FBIO"],"gpt_icon":1},{"id":"2518279023","title":"Buy Rating Affirmed for Mineralys Therapeutics, Inc. Due to Promising Lorundrostat Study Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518279023?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:15","pubTimestamp":1741619713,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda has maintained their bullish stance on MLYS stock, giving a Buy rating today. Rami Katkhuda’s rating is based...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-mineralys-therapeutics-inc-due-to-promising-lorundrostat-study-outcomes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-mineralys-therapeutics-inc-due-to-promising-lorundrostat-study-outcomes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0},{"id":"2518008279","title":"Promising Potential of Lorundrostat Drives Buy Rating for Mineralys Therapeutics, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518008279","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518008279?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:05","pubTimestamp":1741619112,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Matthew Caufield has reiterated their bullish stance on MLYS stock, giving a Buy rating on March 7. Matthew Caufield has gi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-potential-of-lorundrostat-drives-buy-rating-for-mineralys-therapeutics-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-potential-of-lorundrostat-drives-buy-rating-for-mineralys-therapeutics-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS"],"gpt_icon":0},{"id":"2518276406","title":"Mineralys' drug for persistent hypertension succeeds in two trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276406","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518276406?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:02","pubTimestamp":1741618944,"startTime":"0","endTime":"0","summary":"UPDATE 3-Mineralys' drug for persistent hypertension succeeds in two trialsUpdates share move, add details throughout, adds analyst's comments in paragraphs 6 and 7, company comments from conference c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0WQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2324357040.USD","LU1267930813.SGD","LU0114720955.EUR","LU0158827948.USD","LU0823416689.USD","LU0310800965.SGD","LU0738911758.USD","LU0553294199.USD","MLYS","LU0128525689.USD","LU1983299246.USD","LU0949170426.SGD","LU0969580561.USD","LU0047473722.SGD","LU1880407215.USD","LU1323610961.USD","LU0211328371.USD","LU1814569148.SGD","LU1153584641.USD","LU2091194634.USD","LU0266013472.USD","LU0557290698.USD","IE0009355771.USD","LU1003076772.USD","LU1267930490.SGD","LU1023059063.AUD","LU2023251221.USD","SG9999013999.USD","LU0211327993.USD","LU0997586432.USD","LU0496365809.HKD","LU0211326839.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1880407132.USD","LU2089283258.USD","LU0128525929.USD","LU2279689827.SGD","IE00BFTCPJ56.SGD","LU1267930573.SGD","LU1064927863.SGD","03165","LU0976567544.SGD","LU1496350502.SGD","SG9999001176.SGD","LU0310799852.SGD","LU1481600234.SGD","AZN.UK","LU0640478417.SGD"],"gpt_icon":0},{"id":"2518220739","title":"Mineralys Therapeutics Up Over 55%, on Pace for Record Percent Increase -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220739?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:19","pubTimestamp":1741616340,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics, Inc.  is currently at $16.32, up $5.81 or 55.18%. --Would be highest close since June 30, 2023, when it closed at $17.05. --Down 14.71% from its all-time closing high of $19.14 on March 3, 2023. --Up 23.11% from 52 weeks ago , when it closed at $13.26. --Up 86.36% from its 52-week closing low of $8.76 on Feb. 25, 2025. --Traded as high as $16.55; highest intraday level since Feb. 27, 2024, when it hit $16.90. --Up 57.32% at today's intraday high; largest intraday percent increase on record ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2518271852","title":"Goldman Sachs Remains a Buy on Mineralys Therapeutics, Inc. (MLYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518271852?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:57","pubTimestamp":1741615031,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Richard Law CFA maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report) on March 7 and set a price t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-mineralys-therapeutics-inc-mlys?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-remains-a-buy-on-mineralys-therapeutics-inc-mlys?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3B42.SGD","MLYS","CFA","LU2471134879.HKD","BK4533","LU2237443895.HKD","LU2750360641.GBP","LU2237443382.USD","BK4585","LU2237443622.USD","LU2237443549.SGD","LU1868837300.USD","LU0061475181.USD","IE00BFXG1179.USD","LU0096364046.USD","IE0004086264.USD","LU2237443978.SGD","BK4516","BK4550","BK4139","LU1868837136.USD","IE0002270589.USD","IE00B19Z3581.USD","BK4552","LU1868836757.USD","LU2471134952.CNY","IE00BSNM7G36.USD","LU0106831901.USD","LU1868836914.USD","BK4588","LU2471134796.USD","BK4504","BK4127","IE0034235188.USD","LU2471134523.USD","LU1868836591.USD","LU2237438978.USD","LU1668664300.SGD","LU2237443465.HKD","LU2750360997.AUD","IE0004091025.USD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2518837227","title":"Mineralys Therapeutics Shares Hit 52-Week High on Hypertension Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518837227","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518837227?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:57","pubTimestamp":1741615020,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics shares surged to a new 52-week high Monday after the clinical-stage biopharmaceutical company reported positive study results for its lorundrostat drug candidate for the treatment of uncontrolled or resistant hypertension.Shares of the Radnor, Pa., company were recently changing hands at $15.07, up 43%, after touching a 52-week high of $15.64 early in the session.Mineralys said a pair of pivotal studies of lorundrostat achieved statistical significance and were clinically meaningful in their pre-specified primary efficacy endpoints, and that the results demonstrate the opportunity for the drug in third-line or later treatment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","MLYS"],"gpt_icon":0},{"id":"2518224903","title":"Mineralys Therapeutics Shares up 31% After Co's Blood Pressure Drug Meets Goal in Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518224903?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:34","pubTimestamp":1741613649,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT10V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2518221618","title":"BUZZ-U.S. STOCKS ON THE MOVE-Primo Brands, Cracker Barrel, Redfin","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221618","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518221618?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:13","pubTimestamp":1741612386,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Primo Brands, Cracker Barrel, RedfinEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL6N3PT0GJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130518102.USD","LU2360106947.USD","LU1923622614.USD","LU1069347547.HKD","LU0323591593.USD","LU1868836757.USD","LU2237443895.HKD","GB00BDT5M118.USD","LU0128525929.USD","IE00B19Z9Z06.USD","RDFN","TRVI","BECN","BK4604","LU1974910355.USD","BK4229","TKO","CBRL","BK4209","IE00B2B36J28.USD","IE00BK4W5M84.HKD","HUT","LU1868836914.USD","TSYW.SI","IE0004091025.USD","DASH","DXCM","LU0203347892.USD","WSM","IE00BWXC8680.SGD","MLYS","IE0004086264.USD","FBIO","ABNB","IE00B894F039.SGD","LU2023250330.USD","EXE","LU1670628061.USD","RKT","CKPT","LU1057294990.SGD","PRMB","BK4581"],"gpt_icon":1},{"id":"2518223344","title":"Mineralys Therapeutics Says Lorundrostat Met Trial Endpoints for Treating Hypertension; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2518223344","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518223344?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:12","pubTimestamp":1741608769,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  shares were up premarket Monday after the company said lorundrostat met primary endpoints in both the phase 3 Launch-HTN and phase 2 Advance-HTN trials in patients with uncontrolled hypertension or resistant hypertension.The company said the phase 3 study showed a statistically significant drop in systolic blood pressure compared with placebo by week six until week 12.In the phase 2 trial, lorundrostat also led to a statistically significant placebo-adjusted drop of 7.9 mmHg in systolic pressure at week 12, Mineralys said.Mineralys said the treatment was generally well tolerated in both studies, with low rates of serious side effects and elevated potassium levels. The company said it plans to present more data at a medical conference later this month and continue collecting longer-term results in an extension study.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","MLYS"],"gpt_icon":0},{"id":"2518824714","title":"Mineralys Therapeutics Shares Resume Trading, Jump 40% Premarket After Co's Blood Pressure Drug Meets Goal in Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2518824714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518824714?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:31","pubTimestamp":1741606310,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2518624785","title":"CORRECTED-UPDATE 2-Mineralys' blood pressure drug meets goal in trials, shares soar","url":"https://stock-news.laohu8.com/highlight/detail?id=2518624785","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518624785?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:22","pubTimestamp":1741605768,"startTime":"0","endTime":"0","summary":"CORRECTED-UPDATE 2-Mineralys' blood pressure drug meets goal in trials, shares soarCorrects paragraph 3 to say the drug showed reduction of 7.9 mmHg, not 11.7 mmHg, in mid-stage studyMarch 10  - Mineralys Therapeutics MLYS.O said on Monday its experimental  drug met the main goal of lowering blood pressure in patients with uncontrolled or resistant hypertension in late- and mid- stage trials, sending its shares up about 43% before the bell.In the late-stage study, the treatment called lorundrostat showed a placebo-adjusted reduction in systolic blood pressure by 9.1 mmHg  at week six. The benefit was sustained through week 12, with a further reduction to 11.7 mmHg.The drug also reduced systolic blood pressure by 7.9 mmHg in a mid-stage trial when compared to a placebo, the company said.Lorundrostat inhibits the production of aldosterone, a hormone that can contribute to high blood pressure.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":85,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"MLYS","fiscalQuarterEnding":"2025/03","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2025-02-12","symbol":"MLYS","fiscalQuarterEnding":"2024/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.98},{"market":"US","date":"2024-11-11","symbol":"MLYS","fiscalQuarterEnding":"2024/09","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731301200000,"reportTimeType":"post","actualEps":-1.13},{"market":"US","date":"2024-08-13","symbol":"MLYS","fiscalQuarterEnding":"2024/06","expectedEps":-0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.83},{"market":"US","date":"2024-05-09","symbol":"MLYS","fiscalQuarterEnding":"2024/03","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5556,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1749614400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2025-07-25","current":-4.930162,"percent":0.758224,"low":-28.120261,"twenty":-14.706714,"median":-6.670986,"eighty":-4.828181,"high":-2.455206,"avg":-9.342971,"sd":6.138324,"marketCap":929399592},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.982663,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":634011855},{"date":"2024-06-07","current":-7.18498,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":652381815},{"date":"2024-06-14","current":-6.878771,"twenty":-18.699239,"median":-12.004794,"eighty":-7.147798,"marketCap":624578633},{"date":"2024-06-21","current":-6.583498,"twenty":-18.674036,"median":-11.801366,"eighty":-7.108428,"marketCap":597768421},{"date":"2024-06-28","current":-6.397585,"twenty":-18.632904,"median":-11.587276,"eighty":-7.004535,"marketCap":580887918},{"date":"2024-07-05","current":-6.796751,"twenty":-18.599998,"median":-11.08918,"eighty":-6.90283,"marketCap":617131352},{"date":"2024-07-12","current":-7.917695,"twenty":-18.591772,"median":-11.014903,"eighty":-6.90283,"marketCap":718910859},{"date":"2024-07-19","current":-7.217788,"twenty":-18.588966,"median":-10.834579,"eighty":-6.932357,"marketCap":655360728},{"date":"2024-07-26","current":-7.354489,"twenty":-18.580102,"median":-10.505451,"eighty":-6.973914,"marketCap":667772863},{"date":"2024-08-02","current":-6.468669,"twenty":-18.558077,"median":-10.192372,"eighty":-6.88752,"marketCap":587342228},{"date":"2024-08-09","current":-6.025759,"twenty":-18.551128,"median":-10.024815,"eighty":-6.843776,"marketCap":547126910},{"date":"2024-08-16","current":-4.076332,"twenty":-18.496301,"median":-9.845949,"eighty":-6.771136,"marketCap":487818681},{"date":"2024-08-23","current":-4.824282,"twenty":-18.473334,"median":-9.694629,"eighty":-6.684109,"marketCap":577326696},{"date":"2024-08-30","current":-5.156705,"twenty":-18.446961,"median":-9.491619,"eighty":-6.64802,"marketCap":617108036},{"date":"2024-09-06","current":-4.666382,"twenty":-18.432727,"median":-9.462603,"eighty":-6.602089,"marketCap":558430560},{"date":"2024-09-13","current":-4.886612,"twenty":-18.41079,"median":-9.366766,"eighty":-6.532417,"marketCap":584785698},{"date":"2024-09-20","current":-4.865835,"twenty":-18.393266,"median":-9.226167,"eighty":-6.400866,"marketCap":582299364},{"date":"2024-09-27","current":-4.944786,"twenty":-18.318529,"median":-9.18084,"eighty":-6.305758,"marketCap":591747432},{"date":"2024-10-04","current":-5.767531,"twenty":-18.250509,"median":-9.070536,"eighty":-6.252,"marketCap":690206249},{"date":"2024-10-11","current":-5.634562,"twenty":-18.229399,"median":-9.042924,"eighty":-6.143869,"marketCap":674293713},{"date":"2024-10-18","current":-5.983606,"twenty":-18.210635,"median":-8.998552,"eighty":-6.048725,"marketCap":716064120},{"date":"2024-10-25","current":-5.655339,"twenty":-18.194216,"median":-8.973895,"eighty":-5.961361,"marketCap":676780046},{"date":"2024-11-01","current":-5.588854,"twenty":-18.189525,"median":-8.92105,"eighty":-5.849535,"marketCap":668823778},{"date":"2024-11-08","current":-5.834016,"twenty":-18.182489,"median":-8.908316,"eighty":-5.825113,"marketCap":698162517},{"date":"2024-11-15","current":-3.728112,"twenty":-18.13003,"median":-8.863447,"eighty":-5.784153,"marketCap":571344320},{"date":"2024-11-22","current":-4.056108,"twenty":-18.054477,"median":-8.834854,"eighty":-5.738445,"marketCap":621610675},{"date":"2024-11-29","current":-4.147037,"twenty":-18.011266,"median":-8.824542,"eighty":-5.694398,"marketCap":635545903},{"date":"2024-12-06","current":-4.289927,"twenty":-17.971392,"median":-8.704678,"eighty":-5.652845,"marketCap":657444117},{"date":"2024-12-13","current":-3.864506,"twenty":-17.93941,"median":-8.597282,"eighty":-5.622096,"marketCap":592247161},{"date":"2024-12-20","current":-4.007395,"twenty":-17.918728,"median":-8.45617,"eighty":-5.566415,"marketCap":614145375},{"date":"2024-12-27","current":-4.163275,"twenty":-17.89399,"median":-8.38318,"eighty":-5.386048,"marketCap":638034336},{"date":"2025-01-03","current":-4.140542,"twenty":-17.884608,"median":-8.283595,"eighty":-5.230583,"marketCap":634550529},{"date":"2025-01-10","current":-3.205267,"twenty":-17.865843,"median":-8.193856,"eighty":-5.186749,"marketCap":491216763},{"date":"2025-01-17","current":-3.000675,"twenty":-17.75795,"median":-8.130978,"eighty":-5.093743,"marketCap":459862501},{"date":"2025-01-24","current":-3.237742,"twenty":-17.725112,"median":-7.972375,"eighty":-5.030384,"marketCap":496193629},{"date":"2025-01-31","current":-3.344909,"twenty":-17.66738,"median":-7.925786,"eighty":-4.98717,"marketCap":512617290},{"date":"2025-02-07","current":-3.185782,"twenty":-17.600622,"median":-7.886161,"eighty":-4.961636,"marketCap":488230642},{"date":"2025-02-14","current":-2.870012,"twenty":-17.57969,"median":-7.841803,"eighty":-4.929578,"marketCap":510316922},{"date":"2025-02-21","current":-2.679426,"twenty":-17.570308,"median":-7.800135,"eighty":-4.913205,"marketCap":476428689},{"date":"2025-02-28","current":-2.56171,"twenty":-17.532779,"median":-7.76156,"eighty":-4.879413,"marketCap":455497722},{"date":"2025-03-07","current":-2.948489,"twenty":-17.497596,"median":-7.666927,"eighty":-4.847705,"marketCap":524270901},{"date":"2025-03-14","current":-5.032788,"twenty":-17.464759,"median":-7.556805,"eighty":-4.833314,"marketCap":894880035},{"date":"2025-03-21","current":-6.142597,"twenty":-17.410812,"median":-7.474785,"eighty":-4.837364,"marketCap":1092215135},{"date":"2025-03-28","current":-5.337906,"twenty":-17.394393,"median":-7.420413,"eighty":-4.839437,"marketCap":949133010},{"date":"2025-04-04","current":-4.515009,"twenty":-17.356865,"median":-7.381829,"eighty":-4.839437,"marketCap":802813733},{"date":"2025-04-11","current":-4.88916,"twenty":-17.298227,"median":-7.359957,"eighty":-4.826979,"marketCap":869341455},{"date":"2025-04-17","current":-4.870916,"twenty":-17.237243,"median":-7.346287,"eighty":-4.83217,"marketCap":866097643},{"date":"2025-04-25","current":-4.867268,"twenty":-17.117621,"median":-7.217788,"eighty":-4.83083,"marketCap":865448881},{"date":"2025-05-02","current":-5.626182,"twenty":-17.049602,"median":-7.174044,"eighty":-4.83217,"marketCap":1000391435},{"date":"2025-05-09","current":-5.345238,"twenty":-17.026147,"median":-7.146704,"eighty":-4.837056,"marketCap":950436740},{"date":"2025-05-16","current":-5.307011,"twenty":-16.932326,"median":-7.108428,"eighty":-4.838863,"marketCap":1000440655},{"date":"2025-05-23","current":-5.642373,"twenty":-16.739993,"median":-7.070152,"eighty":-4.844431,"marketCap":1063660683},{"date":"2025-05-30","current":-5.414189,"twenty":-16.571115,"median":-7.048279,"eighty":-4.857525,"marketCap":1020644994},{"date":"2025-06-06","current":-5.40036,"twenty":-16.559387,"median":-6.993599,"eighty":-4.86168,"marketCap":1018037982},{"date":"2025-06-13","current":-5.158346,"twenty":-16.512477,"median":-6.906111,"eighty":-4.865835,"marketCap":972415282},{"date":"2025-06-20","current":-4.746923,"twenty":-16.418656,"median":-6.878771,"eighty":-4.854252,"marketCap":894856690},{"date":"2025-06-27","current":-4.840271,"twenty":-16.273234,"median":-6.854165,"eighty":-4.839875,"marketCap":912454018},{"date":"2025-07-03","current":-5.026967,"twenty":-16.102011,"median":-6.815889,"eighty":-4.834459,"marketCap":947648672},{"date":"2025-07-11","current":-5.061541,"twenty":-16.001153,"median":-6.774878,"eighty":-4.830927,"marketCap":954166201},{"date":"2025-07-18","current":-4.95782,"twenty":-15.757219,"median":-6.718225,"eighty":-4.834459,"marketCap":934613615},{"date":"2025-07-25","current":-4.930162,"twenty":-14.706714,"median":-6.670986,"eighty":-4.828181,"marketCap":929399592}],"updateTime":1753714110566}}}